menu
Main Data: 31/12 Year 2004 | |
Consolidated statement of income (international practice in accordance with IAS/IFRS) | Millions/Euro |
– total revenues | 371.10 |
– gross margin | 148.41 |
– total operating cost | 111.06 |
– net operating profit | 32.00 |
– financial expenses, net | 4.18 |
– net income before taxes | 13.30 |
Consolidated balance sheet | Millions/Euro |
– operating capital | 75.12 |
– fixed assets, net | 110.48 |
– reserves and MLT non financial payables | – 17.51 |
– net financial position | – 71.58 |
– stockholders’ equity | 96.51 |
Other information | Millions/Euro |
– depreciation | 15.86 |
– R & D expenses | 17.35 |
Euro | |
Dividend per share | 0.40 |
No. | |
Employees | 2,480 |
Euro | |
Share outstanding | 18,772,000 |
Main Data: 30/06 Year 2004 | |
Consolidated statement of income (international practice in accordance with IAS/IFRS) | Millions/Euro |
– total revenues | 150.48 |
– gross margin | 61.63 |
– total operating cost | 54.95 |
– net operating profit | 4.13 |
– financial expenses, net | 2.25 |
– net income before taxes | 1.83 |
Consolidated balance sheet | Millions/Euro |
– operating capital | 86.96 |
– fixed assets, net | 100.81 |
– reserves and MLT non financial payables | -14.32 |
– net financial position | 87.53 |
– stockholders’ equity | 85.92 |
Other information | Millions/Euro |
– depreciation | 7.50 |
– R & D expenses | 9.14 |
No. | |
Employees | 2,438 |
Euro | |
Share outstanding | 18,772,000 |
Net sales by sector: Year 2004 | ||
Millions/Euro | ||
tea, herbs & coffee | 65.69 | 17.70% |
pharmaceuticals packaging | 202.09 | 54.46% |
pharmaceuticals processing | 103.32 | 27.84% |
Total | 371.10 | 100.00% |
Net sales by Country: Year 2004 | ||
Millions/Euro | ||
E.U. (excluding Italy) | 150.42 | 40.53% |
Other European countries | 26.06 | 7.02% |
North America | 75.13 | 20.25% |
Asia & Middle East | 54.42 | 14.66% |
Other countries | 34.36 | 9.26% |
Total exports | 340.39 | 91.72% |
Italy | 30.71 | 8.28% |
Total | 371.10 | 100.00% |